Aurora Cannabis ACB
NASDAQ ACB
$3.79 -0.12 (-3.07%)
At close: Aug 20, 2026 · 2:59 PM UTC

Aurora Cannabis (ACB) Non-Current Deferred Tax Liability (2018 - 2025)

Aurora Cannabis (ACB) posted quarterly Non-Current Deferred Tax Liability of $2.5 million for Q4 2025, up 269.28% year-over-year from $675761.6 in Q4 2024, and down 1.37% quarter-over-quarter from $2.5 million in Q3 2025.

Aurora Cannabis (ACB) Non-Current Deferred Tax Liability (2018 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has reported Non-Current Deferred Tax Liability for 8 consecutive years, with $2.5 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Non-Current Deferred Tax Liability rose 269.28% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $2.5 million (up 269.28% YoY), while the FY2025 annual figure was $1.4 million, up 1194.95% from the prior year.
  • Non-Current Deferred Tax Liability slipped to $2.5 million in Q4 2025 per ACB's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $30.5 million in Q1 2023 and bottomed at $105380.1 in Q1 2024.
  • Historically, Non-Current Deferred Tax Liability has averaged $9.5 million across 5 years, with a median of $11.4 million in 2024.
  • Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability sank 99.65% — and 2025, when it soared 1154.55%.
  • Aurora Cannabis' Non-Current Deferred Tax Liability stood at $24.1 million in 2021, then plunged by 49.93% to $12.1 million in 2022, then fell by 0.62% to $12.0 million in 2023, then plunged by 94.37% to $675761.6 in 2024, then surged by 269.28% to $2.5 million in 2025.
  • Business Quant data shows ACB's Non-Current Deferred Tax Liability at $2.5 million in Q4 2025, $2.5 million in Q3 2025, and $1.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.94 Bn 42.97 Bn -
2 Teva Pharmaceutical Industries 43.08 Bn 39.43 Bn 2.15 Bn
3 Zoetis 31.54 Bn 29.87 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn
5 United Therapeutics 22.12 Bn 19.46 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn -
10 Aurora Cannabis 233.45 Mn 161.14 Mn 25.75 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.50 Mn
Dec 31, 2025 2.50 Mn
Sep 30, 2025 2.53 Mn
Sep 30, 2025 2.53 Mn
Jun 30, 2025 1.38 Mn
Jun 30, 2025 1.38 Mn
Mar 31, 2025 1.32 Mn
Mar 31, 2025 1.32 Mn
Dec 31, 2024 675,761.59
Dec 31, 2024 675,761.59
Sep 30, 2024 11.37 Mn
Sep 30, 2024 11.37 Mn
Jun 30, 2024 12.86 Mn
Jun 30, 2024 12.86 Mn
Mar 31, 2024 105,380.08
Mar 31, 2024 105,380.08
Dec 31, 2023 11.99 Mn
Dec 31, 2023 11.99 Mn
Sep 30, 2023 12.36 Mn
Sep 30, 2023 12.36 Mn